TSX higher on employment data
Director Ashiya Mona reported purchasing 6,306,127 shares of Shattuck Labs, Inc. (NASDAQ:STTK) common stock at a price of $0.8677 on August 25, 2025, for a total transaction value of $5,471,826. The purchase price represents a significant discount to the current trading price of $1.01, with the stock showing strong momentum over the past month according to InvestingPro data.
The purchases were made in two tranches. The first tranche consisted of 5,255,106 shares, and the second tranche consisted of 1,051,021 shares. With a market capitalization of $47.9 million and trading below book value, InvestingPro analysis suggests the stock is currently undervalued.
The report also details the purchase of Pre-Funded Warrants and Common Warrants, representing the right to buy additional shares of Shattuck Labs common stock. These transactions involved the purchase of 12,133,661 Pre-Funded Warrants and 18,439,788 Common Warrants. InvestingPro indicates volatile stock price movements and reveals 10 additional investment insights available to subscribers.
In other recent news, Shattuck Labs announced the successful closing of a private placement led by OrbiMed, raising approximately $103 million. The funds are intended to support the company’s operations into 2029 and advance the clinical development of SL-325, a DR3 blocking antibody. Additionally, the FDA has cleared Shattuck Labs’ Investigational New Drug application for SL-325, allowing the company to proceed with a Phase 1 clinical study targeting inflammatory bowel disease. Despite this progress, Leerink Partners has lowered its price target for Shattuck Labs to $2.00 from $4.00, while maintaining an Outperform rating. The adjustment follows Shattuck’s recent earnings report and pipeline update, which included plans to initiate a Phase 1 trial for SL-325 this quarter. Meanwhile, H.C. Wainwright has reiterated its Neutral rating on the stock. Furthermore, Shattuck Labs held its 2025 Annual Meeting of Stockholders, where all director nominees were elected and the independent auditor was ratified. These developments reflect ongoing strategic and operational activities at the company.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.